Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Managing homozygous familial hypercholesterolaemia from cradle to grave.

Atherosclerosis. Supplements - 1 May 2015

Thompson Gilbert R

Abstract excerpt

OBJECTIVE: To describe the phenotypic and genotypic features and management of clinically homozygous familial hypercholesterolaemia (FH). METHODS: An analysis of current knowledge based on personal experience and published evidence. RESULTS: Atherosclerotic involvement of the aortic root is common in homozygous FH and can cause death before age 5. Receptor negative patients are at greatest risk, irrespective of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age Factors
Share to Anticholesteremic Agents
Share to Blood Component Removal

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cholesterol, LDL

Share to Drug Therapy, Combination

Share to Heredity

Share to Hyperlipoproteinemia Type II

Share to Receptors, LDL

Source

Identifiers

PMID: 25936299
DOI: 10.1016/j.atherosclerosissup.2015.02.002

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Managing homozygous familial hypercholesterolaemia from cradle to grave.PMID 25936299Read ↗

Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society.Semantic proximity Read ↗

Current management of severe homozygous hypercholesterolaemias.Semantic proximity Read ↗

Management of autosomal recessive hypercholesterolemia in a patient with an LDLRAP1 mutation.Semantic proximity Read ↗

Current treatments for the management of homozygous familial hypercholesterolaemia: a systematic review and commentary.Semantic proximity Read ↗

Evidence for improved survival with treatment of homozygous familial hypercholesterolemiaSemantic proximity Read ↗

Homozygous familial hypercholesterolemia: current perspectives on diagnosis and treatment.Semantic proximity Read ↗

Familial hypercholesterolaemia: history, diagnosis, screening, management and challengesSemantic proximity Read ↗

New treatments on the horizon for familial hypercholesterolemia.Semantic proximity Read ↗

From physiopathology to treatment of familial hypercholesterolemia: Existing and emerging pharmacotherapies.Semantic proximity Read ↗

HEART UK statement on the management of homozygous familial hypercholesterolaemia in the United Kingdom.Semantic proximity Read ↗

Improved lipid-lowering treatment and reduction in cardiovascular disease burden in homozygous familial hypercholesterolemia: The SAFEHEART follow-up study.Semantic proximity Read ↗

Improved cardiovascular outcomes following temporal advances in lipid-lowering therapy in a genetically-characterised cohort of familial hypercholesterolaemia homozygotes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.